Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for ...

We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.” ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

Rhythm Pharmaceuticals said on Monday its experimental drug to treat a rare obesity disorder met the main goal in a late-stage trial. The therapy setmelanotide showed a significant reduction in body ...

This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 treatments.

Neurodegenerative disorders have increasing incidence with limited treatment options. Approaches to target neuroinflammation in various neurodegenerative disorders, such as Alzheimer’s disease (AD), ...

An anonymous source provided FOX6 Investigators with a complete list of customers who purchased beagle puppies in 2019 and ...

Roche Holding said it will initiate a late-stage trial for its Alzheimer's drug candidate trontinemab later this year after its mid-stage study showed positive results.

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

Brian Fiske, chief scientist at The Michael J. Fox Foundation for Parkinson’s Research, which funded some of Dr ...

BeiGene is ending development of its experimental lung-cancer treatment ociperlimab following the failure of a late-stage study. BeiGene on Thursday said it is stopping a Phase 3 trial of ociperlimab ...

Today, there is no approved pill that can reliably treat severe obesity on its own. Obesity affects over 40% of adults in the United States and is linked to serious health issues like heart disease, ...